Skip to content

Research on Effective Follow-up Procedures During the Medication Period - Utilization of Tracing Report Template -

Research on Effective Follow-up Procedures During the Medication Period - Utilization of Tracing Report Template - - Research on Effective Follow-up Procedures During the Medication Period - Utilization of Tracing Report Template -

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000051057
Enrollment
480
Registered
2023-05-15
Start date
2023-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Constipation, Sleep disorders, Overactive bladder

Interventions

None listed

Sponsors

Niigata University of Pharmacy and Applied Life Sciences
Lead Sponsor
mSEED Co,. Ltd. Sado Pharmacy Shinano Pharmacy Medic Taiyo Ltd. KAKEHASHI Inc.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients 1. Those who are at least 18 years of age and visited the participating institutions during the study period. 2. Those who were eligible to submit a tracing report. 3. Those who understood the opt-out document and did not refuse to cooperate. Pharmacists 1. Those who received an explanation of the implementation procedures from the principal investigator at the research site and who attended to patients who were eligible to submit a tracing report. 2. Those who gave consent

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
Changes in the number of tracing reports submitted by pharmacists to attending physicians on the subject drug

Secondary

MeasureTime frame
1. Changes in the number of tracing reports submitted for all drugs, including those not covered in this study 2. Changes in the content of text information in tracing reports 3. Change in the number of additional service fee of the NHI system 4. Change in the percentage of the number of tracing reports generated out of the number of follow-ups during the medication period

Countries

Japan

Contacts

Public ContactYoshiko Tominaga

Niigata University of Pharmacy and Applied Life Sciences School of Pharmacy, Laboratory of Social Pharmacy

y-tominaga@nupals.ac.jp0250-28-5306

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026